Steven Cohen’s Damora Therapeutics DMRA Stock Holding History
Bought
Maintained
Sold
Other funds holding DMRA
Steven Cohen's DMRA Position: Q3 2026 in Review
Steven Cohen sold out of Damora Therapeutics (DMRA) in Q3 2026, closing a stake of 48,754 shares — an estimated $1.27M sold.
Steven Cohen first reported a position in DMRA in Q4 2025 and held it in 3 quarters. The position peaked at $30.9M in Q1 2026. 115 funds tracked by Wall St. Rank hold DMRA as of Q3 2026.
- Steven Cohen reported no remaining Damora Therapeutics position as of Q3 2026 after selling out during the quarter.
- Steven Cohen sold 48,754 Damora Therapeutics shares in Q3 2026, an estimated $1.27M.
- Steven Cohen first reported a position in Damora Therapeutics in Q4 2025 and held it in 3 quarters.
- Steven Cohen's Damora Therapeutics position peaked at $30.9M in Q1 2026.
- 115 funds tracked by Wall St. Rank held Damora Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.